C07D 233/92
Attached in position 4 or 5
Official title: attached in position 4 or 5
C07D233/92 (Attached in position 4 or 5) appears on 206 US grants and 84 published applications in this corpus.
Search patents in C07D- Granted patents
- 206
- Published applications
- 84
- Assignees
- 111
- Inventors
- 473
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 21 | 0 |
| 1978 | 7 | 0 |
| 1979 | 3 | 0 |
| 1980 | 6 | 0 |
| 1981 | 5 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 6 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 7 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 6 | 0 |
| 2002 | 4 | 1 |
| 2003 | 1 | 5 |
| 2004 | 2 | 2 |
| 2005 | 2 | 1 |
| 2006 | 3 | 4 |
| 2007 | 3 | 5 |
| 2008 | 1 | 2 |
| 2009 | 5 | 2 |
| 2010 | 2 | 4 |
| 2011 | 0 | 4 |
| 2012 | 4 | 2 |
| 2013 | 1 | 4 |
| 2014 | 3 | 2 |
| 2015 | 3 | 4 |
| 2016 | 2 | 4 |
| 2017 | 4 | 2 |
| 2018 | 1 | 5 |
| 2019 | 2 | 4 |
| 2020 | 6 | 7 |
| 2021 | 6 | 7 |
| 2022 | 2 | 3 |
| 2023 | 3 | 5 |
| 2024 | 3 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- N-(3-amino-3-oxopropyl)-2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]benzamide and its use for treating HIV infection17 Feb 2026US 12,551,464 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof24 Dec 2024US 12,172,969 B2Evofem Biosciences, Inc.
- Linker containing arylnitro, antibody-drug conjugate containing linker and use of linker15 Oct 2024US 12,115,226 B2Academy of Military Medical Sciences
- YAP1 inhibitors that target the interaction of YAP1 with OCT44 Jun 2024US 11,999,695 B2H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Compounds and methods for the treatment of dermal and ocular disorders30 Jul 2026US 2026/0216173 A1Azura Ophthalmics Ltd.
- Method and system for fully continuous-flow preparation of nitroimidazole antimicrobial agent9 Apr 2026US 2026/0098016 A1Fudan University
- Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof30 Oct 2025US 2025/0333384 A1Evofem Biosciences, Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Full continuous synthesis device and method for metronidazole15 Aug 2024US 2024/0270696 A1Fudan University
Most cited
By later US patents
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- Angiotensin II receptor blocking imidazoles119US 5,138,069 AE. I. Du Pont de Nemours and Company · 1992
- Pharmaceutically active compounds72US 5,272,167 ASchering Corporation · 1993